Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    Open Studies | "Dysentery"
Show Display Options
Rank Status Study
1 Not yet recruiting SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Interventions: Biological: SF2a-TT15 vaccine;   Biological: SF2a-TT15 vaccine + adjuvant;   Biological: Placebo;   Biological: Placebo + adjuvant
2 Recruiting Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Intervention: Biological: Shigella flexneri 2a InvaplexAR
3 Recruiting Auranofin Trial for GI Protozoa
Conditions: Amoebic Dysentery;   Giardiasis
Interventions: Drug: Auranofin;   Other: Placebo
4 Not yet recruiting Shigella Sonnei 53G Challenge
Condition: Healthy
Intervention: Biological: Shigella sonnei 53G
5 Recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
6 Not yet recruiting A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
Condition: Travelers' Diarrhea
Interventions: Drug: Rifaximin (Sandoz GmbH) tablet;   Drug: Rifaximin (Xifaxan);   Drug: Placebo
7 Recruiting Etiological Diagnosis of Traveler's Diarrhoea
Condition: Traveler's Diarrhoea
Intervention: Other: Rectal swab
8 Not yet recruiting Clinical Trial of CBS-2004 (Bimuno)® in Prevention of Travelers' Diarrhea
Condition: Traveler's Diarrhea
Interventions: Drug: Bimuno® (galacto-oligosaccharides);   Drug: Placebo
9 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
10 Recruiting Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Conditions: Travelers' Diarrhea;   Functional Bowel Disorders;   Reactive Arthritis
Interventions: Drug: Rifaximin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.